Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

Abstract

Background MicroRNAs (miRNAs) are involved in the prognosis of nasopharyngeal carcinoma (NPC). This study used clinical data and expression data of miRNAs to develop a prognostic survival signature for NPC patients to detect high-risk subject. Results We identified 160 differentially expressed miRNAs using RNA-Seq data from the GEO database. Cox regression model consisting of hsa-miR-26a, hsa-let-7e, hsa-miR-647, hsa-miR-30e, and hsa-miR-93 was constructed by the least absolute contraction and selection operator (LASSO) in the training set. All the patients were classified into high-risk or low-risk groups by the optimal cutoff value of the 5-miRNA signature risk score, and the two risk groups demonstrated significant different survival. The 5-miRNA signature showed high predictive and prognostic accuracies. The results were further confirmed in validation and external validation set. Results from multivariate Cox regression analysis validated 5-miRNA signature as an independent prognostic factor. A total of 13 target genes were predicted to be the target genes of miRNA target genes. Both PPI analysis and KEGG analysis networks were closely related to tumor signaling pathways. The prognostic model of mRNAs constructed using data from the dataset GSE102349 had higher AUCs of the target genes and higher immune infiltration scores of the low-risk groups. The mRNA prognostic model also performed well on the independent immunotherapy dataset Imvigor210. Conclusions This study constructed a novel 5-miRNA signature for prognostic prediction of the survival of NPC patients and may be useful for individualized treatment of NPC patients.

Identification and validation of prognostic genes and immune landscape signatures based on a fatty acid oxidation‑related risk score model in glioma

“…Validation set validates scoring model performance. Given the absence of a glioma-specific immunotherapy database and the pan-cancer attributes of immunotherapy, certain datasets containing abundant immunotherapy sample data were selected as validation sets (26)(27)(28). The two independent validation datasets, GSE135222 (29) and GSE61676 (30), were downloaded from the Gene Expression Omnibus website (https://www.…”

Identification of Key microRNAs and Genes in Infantile Hemangiomas

“…An extensive number of studies have demonstrated that miRNAs are involved in various biological processes, including tumor angiogenesis and vascular-related disorders ( Pourrajab et al, 2015 ; Mashreghi, 2017 ). In addition, some miRNAs have been reported as biomarkers of specific diseases ( Mariam et al, 2022 ), especially in tumors ( Li et al, 2022 ; Tu et al, 2022 ). Nonetheless, there are fewer studies focused on the comprehensive miRNA-gene interaction in IH.…”

Diagnostic and prognostic value of long non-coding RNA PROX1‑AS1 and miR-647 expression in gastric cancer

“…Изменение экспрессии микроРНК miR-647 было обнаружено во многих опухолях, включая карциному носоглотки [14], гепатоцеллюлярную карциному [15], колоректальный рак [16] и РЖ [17]. Снижение экспрессии miR-647 в сыворотке крови пациентов с РЖ коррелирует с неблагоприятным прогнозом [18].…”